Non-tuberculous mycobacteria (NTM), also called atypical mycobacteria, environmental mycobacteria or mycobacteria other than tuberculosis (MOTT), are a large group of rod-shaped bacteria related to the germ that causes tuberculosis (TB). They live in soil and water all over the world, including treated tap water, swimming pools, spas, humidifiers, aquariums, garden soil and food. A waxy cell wall makes them resistant to disinfectants and water treatment.
About half of the known species can cause infections, mostly in people whose defences are weakened. They enter the body when contaminated water droplets, soil or dust are breathed in or swallowed, or through breaks in the skin from injuries, surgery or intravenous catheters.
Anyone can be infected, but people with a weakened immune system, such as those with HIV or transplant recipients, and people with damaged lungs from smoking, past TB, emphysema or cystic fibrosis are most at risk. Treatment can be long and difficult because many species resist common antibiotics.
The Mycobacterium avium complex (MAC) is widespread and is one of the commonest infections in people with HIV or AIDS, often affecting the lungs and spreading through the body. M. kansasii most often causes lung infections, and M. xenopi is found in hot water systems.
M. abscessus, M. chelonae and M. fortuitum can infect surgical sites and implanted devices such as pacemakers, artificial heart valves and prostheses. M. scrofulaceum can inflame the lymph nodes of the neck, especially in children. M. marinum lives in fresh and salt water, aquariums and pools and causes stubborn skin sores through breaks in the skin. M. ulcerans, found in the tropics, causes the large skin lesions known as Buruli ulcer. M. leprae, the cause of leprosy, affects the skin and nerves, causing numbness and skin nodules.
Symptoms depend on which part of the body is infected. Lung infections can resemble TB, with a long-lasting cough that sometimes brings up blood, fever, chills, weight loss and weakness.
Skin infections may cause persistent sores, boils, ulcers and small inflammatory lumps (granulomas), while infected lymph nodes become inflamed.
Because many other illnesses cause the same symptoms, diagnosis usually depends on finding mycobacteria in body fluids or tissue. Leprosy is the exception: M. leprae will not grow in culture, so it is diagnosed mainly from its clinical signs.
Testing aims to detect the infection, tell it apart from TB, which is impossible without laboratory tests, and identify the species. For lung infections, three to five early-morning sputum samples are collected on different days. For other sites, swabs, fluids, washings or tissue samples may be taken.
In an AFB smear, the sample is specially stained and examined under the microscope; all mycobacteria show up as acid-fast bacteria, so a positive smear is treated as possible TB until more results are available. AFB culture is the definitive test: it identifies the organism and the drugs likely to kill it, but because mycobacteria grow slowly, results take weeks. Smears and cultures are also repeated to check how well treatment is working.
Faster molecular tests that detect the organism's DNA or RNA, and analysis of mycolic acids in the cell wall, can help identify the species. Chest X-rays may show changes typical of mycobacterial infection.
The aim is to clear the infection and prevent further damage to tissues and organs. Treatment usually combines more than one antibiotic over a long period, with its length guided by repeated AFB smears and cultures. Some infections, such as Buruli ulcer, are best treated by surgically removing the damaged skin, and a localised infection such as an infected lymph node may be removed by surgery.
Symptoms often improve after a few weeks, but it is essential to keep taking the medicines for as long as your doctor advises, since killing all the bacteria can take months or longer.
Unlike TB, these infections do not usually pass from person to person; leprosy spreads only after prolonged close contact. Because most species grow slowly, an infection may appear weeks, months or even years after exposure. When many people are infected from a shared source, the source is traced and removed.